国泰创新医疗混合发起C(018160)资产负债表
|
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
资产 |
银行存款 |
- |
- |
- |
- |
结算备付金 |
147,043.04 |
126,380.38 |
23,619.40 |
74,846.67 |
存出保证金 |
6,249.55 |
4,472.90 |
6,029.42 |
7,631.40 |
交易性金融资产 |
16,987,236.16 |
13,794,511.50 |
14,508,026.32 |
24,281,918.48 |
其中:股票投资 |
16,181,137.42 |
13,082,429.09 |
13,798,561.08 |
23,474,146.43 |
债券投资 |
806,098.74 |
712,082.41 |
709,465.24 |
807,772.05 |
资产支持证券投资 |
- |
- |
- |
- |
衍生金融资产 |
- |
- |
- |
- |
买入返售金融资产 |
- |
- |
- |
- |
应收证券清算款 |
163,064.90 |
53,403.79 |
- |
144,850.06 |
应收利息 |
- |
- |
- |
- |
应收股利 |
- |
- |
7,677.31 |
- |
应收申购款 |
18,415.48 |
1,099.94 |
2,143.17 |
93,104.03 |
其他资产 |
- |
- |
- |
- |
资产总计 |
17,726,817.23 |
14,233,805.24 |
14,799,851.01 |
25,390,719.49 |
负 债 |
短期借款 |
- |
- |
- |
- |
交易性金融负债 |
- |
- |
- |
- |
衍生金融负债 |
- |
- |
- |
- |
卖出回购金融资产款 |
- |
- |
- |
- |
应付证券清算款 |
355,279.45 |
3,581.88 |
32,970.34 |
63,221.11 |
应付赎回款 |
104,726.51 |
67,250.28 |
2,649.59 |
70,893.54 |
应付管理人报酬 |
16,977.88 |
14,952.68 |
15,472.28 |
26,667.18 |
应付托管费 |
2,829.66 |
2,492.13 |
2,578.71 |
4,444.54 |
应付销售服务费 |
1,909.98 |
2,099.75 |
2,443.32 |
5,699.44 |
应付交易费用 |
- |
- |
- |
- |
应交税费 |
- |
- |
- |
- |
应付利息 |
- |
- |
- |
- |
应付利润 |
- |
- |
- |
- |
其他负债 |
27,070.55 |
72,879.88 |
51,359.38 |
162,099.58 |
负债合计 |
508,794.03 |
163,256.60 |
107,473.62 |
333,025.39 |
所有者权益 |
实收基金 |
17,432,361.94 |
18,445,739.40 |
20,167,379.34 |
24,664,050.38 |
未分配利润 |
-214,338.74 |
-4,375,190.76 |
-5,475,001.95 |
393,643.72 |
所有者权益合计 |
17,218,023.20 |
14,070,548.64 |
14,692,377.39 |
25,057,694.10 |
负债及所有者权益总计 |
17,726,817.23 |
14,233,805.24 |
14,799,851.01 |
25,390,719.49 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年